Levine Co-authors Article on Value of Real-time Data in Cell Therapy

Posted May 18, 2022

Aaron Levine, associate professor in the School of Public Policy and associate dean for research and outreach in the Ivan Allen College of Liberal Arts, co-authored an article published in Current Opinion in Biomedical Engineering. The piece is titled “Commercial Autologous Cell Therapy: The Value of Real-Time Patient and Therapy Data.”

In it, the authors discuss the role that real-time data can play in autologous cell therapy manufacturing. They note that access to real-time data has already benefitted several industries and believe that the same could be true for that of cell therapy manufacturing.

“Several examples have illustrated that this value can be significant,” they write. “Moving toward a more flexible and adaptive manufacturing processes for autologous cell therapies would require changes to the current regulatory structure but could potentially help the industry improve clinical outcomes and manage costs.”

Read the full article at https://doi.org/10.1016/j.cobme.2022.100389.